في هذا العدد من برنامج "الصحة أولا"، تستضيف صونيتا ناضر اختصاصية التغذية سينتيا بو خليل، لفتح ملف التالي: كيف نخفض مستويات الكورتيزول المرتفعة من دون أدوية؟. كما نشاهد تقريرا عن دراسة دنماركية حديثة تشير إلى تأثير مستويات الكورتيزول المرتفعة أثناء الحمل على ذكاء الأطفال.

Streamed live on Sep 21, 2026 Hosted by: Fraser Cain (@frasercain) and Dr. Pamela L. Gay (@CosmoQuest) Today we begin a new series on rockets and spacecraft, dealing with each of their components. It’s a big job, so it’ll take us a bunch of episodes to get through. Today let’s do an introduction about what we’re gonna talk about in this series: rockets from tip to tail, soup to nuts.

In his weekly clinical update, Daniel Griffin and Vincent Racaniello frustration continues over the increasing number of measles infections, Kennedy’s undermining of vaccines, perpetuation of autism- vaccine, autism-tylenol myths, an outbreak of hepatitis A virus in the US, the Ebola outbreak in Uganda, changes in reporting of virus infection and vaccine recommendations, Legionnaires disease and screw worm cases, and before Dr. Griffin deep dives into recent statistics RSV, influenza, SARS-CoV-2

在科学家对比的众多食物里，咖啡与肠道菌群的关联最强，其中一种菌在爱喝咖啡的人体内格外丰富——就连喝脱因咖啡的人也一样。真正起作用的，可能不是咖啡因，而是咖啡里的多酚类物质。你每天吃的东西，能显著预测肠道里绝大多数菌种的变化；而食物的加工程度，比荤素更能决定菌群的多样性。每一口饭，都在喂养你的菌群。

Guest: John Cho, MD, PhD, FRCPC Could lower doses of radiation help optimize immune response in mesothelioma? Dr. John Cho joins us to explain how tailoring radiation to a tumor’s inflammatory and immunogenic characteristics could help modulate antitumor immunity while reducing the potential for fibrosis and treatment-related toxicity. Dr. Cho is a radiation oncologist at the Princess Margaret Cancer Centre and an Associate Professor in the Department of Radiation Oncology at the

In this episode Adam Neiman discusses his article "Efficacy of Resistance Training in Reducing Injury Risk and Managing Performance-Related Musculoskeletal Disorders in Instrumental Musicians" published in issue 48-5 of Strength and Conditioning Journal.

Vi vender noget af alt det, der er sket siden vi sidst optog midt på sommeren. 1: Space X - Flight 142: Nancy Grace Roman Space Telescope3: Månen har fået 2 nye kratere:3.1: Space Debris Impact Event Aug. 5th3.2: Asteroide impact: McGetchin Crater4: Hvad hvis vi havde haft en månebase?5: Pga. 2024 YR4 somIKKErammer Jorden i 2032--Topic 1: Starship Flight 14 – "It Finally Reached Orbit!"Yesterday, September 28, 2026, SpaceX launchedStarship Flight 14from Starbase, Texas, and achieved its biggest

Eye On The Night Sky For Thursday, October 1

In this episode, I revisit Kodiak Sciences’ DAYBREAK readout for Zenkuda after getting the trade wrong. I break down what the 54% Q24 result really means, how the trial design and loading regimen may have shaped the durability headline, why payer step therapy could change the real-world patient population, and what I missed going into the catalyst. I also compare Zenkuda with Eylea HD and discuss what the data do—and don’t—tell us about the commercial opportunity for $KOD. #KodiakSciences #Biotech

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the pros and cons of wearable devices, new data for thrombectomy use in medium-vessel occlusion strokes, and a new treatment for limb-girdle muscular dystrophy type 2I/R9.

Guest: Alice T. Shaw, MD, PhD Despite advances in ALK inhibition, resistance remains an important challenge in metastatic ALK+ non-small cell lung cancer (NSCLC). Dr. Alice Shaw, Chair of the Department of Medical Oncology at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School, explores patterns of disease progression, emerging on- and off-target resistance mechanisms, and the potential role of combination approaches in overcoming resistance.

Guest: Alice T. Shaw, MD, PhD In metastatic non-small cell lung cancer (mNSCLC), resistance to ALK TKIs can differ depending on which therapies a patient has previously received, with important implications for next steps in treatment. Dr. Alice Shaw explains how treatment history and molecular testing at progression can help identify ALK-dependent and other actionable resistance mechanisms to help inform next-line therapy. She's the Chair of the Department of Medical Oncology at

Guest: Alice T. Shaw, MD, PhD Despite major advances in targeted therapy for ALK+ metastatic non-small cell lung cancer (mNSCLC), challenges remain in achieving durable responses and preventing treatment resistance. Hear from Dr. Alice Shaw as she explores key unanswered questions and emerging research aimed at addressing gaps in care for these patients. Dr. Shaw is the Chair of the Department of Medical Oncology at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard

Guest: Laura Chiavaroli, PhD How might diet and exercise influence metabolic outcomes among patients taking GLP-1 medicines? To find out, we recently spoke with Dr. Laura Chiavaroli, who discussed this topic at the 2026 European Association for the Study of Diabetes Annual Meeting. She shares emerging evidence on combining lifestyle interventions with GLP-1 therapy and highlights where gaps in research still remain. Dr. Chiavaroli is an Assistant Professor in the Department of

Guest: Edward Phelps, PhD Residual beta cells may persist after a type 1 diabetes (T1D) diagnosis, but how well do they continue to function? Tune in to hear Dr. Edward Phelps discuss research he presented at the 2026 European Association for the Study of Diabetes Annual Meeting that examined glucose-stimulated calcium responses in living pancreatic tissue from donors with recent-onset T1D. He explains how residual beta cells showed impaired responses to glucose regardless of the local

Guest: Vira Kravets, PhD Cellular interactions within pancreatic islets may provide important insights into the early stages and pathogenesis of type 1 diabetes (T1D). Tune in to hear Dr. Vira Kravets share research she presented at the 2026 European Association for the Study of Diabetes Annual Meeting, which focused on how alpha-beta cell proximity influences GLP-1R-mediated communication as well as the spatial association between alpha cells and T cells in human islets. Dr. Kravets

Guest: Edward Phelps, PhD Despite advances in type 1 diabetes (T1D) research, key questions remain about disease progression, immune mechanisms, and the optimal timing of intervention. Here to explore how immunology and islet research could help address these knowledge gaps is Dr. Edward Phelps. He’s an Associate Professor in the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida.

听力下降约等于大脑断网：耳朵收不到信号，大脑被迫过载、社交掉线、认知储备加速流失。研究显示，高危老人戴上助听器，3年认知衰退减缓近一半。别让“耳背”偷走父母的大脑——本期聊聊听力与大脑的隐秘连接。

Starfish anatomy. If you want to know the parts, according to Dutch Wikipedia, they are: Legend 1 Arm 2 Ampullae 3 Radial canal 4 Gonads [...]The post Science Art: Dissection of Asterias rubens, by Hans Hillewaert. first appeared on The Guild of Scientific Troubadours.

In this podcast, we summarise the reviews and original articles in Volume 68, Issue 10 of Developmental Medicine & Child Neurology. The issue is available here: https://onlinelibrary.wiley.com/toc/14698749/2026/68/10 Generated by Gauff speech synthesis using MS Edge TTS licensed under MIT License. Follow DMCN on Podbean for more:  https://dmcn.podbean.com/ ___ Watch DMCN Podcasts on YouTube: https://bit.ly/2ONCYiC __ DMCN Journal: Developmental Medicine & Child Neurology (DMCN) has defined